Viola Franke MD
PhD Candidate, Surgical Oncology, Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The NetherlandsDr. Viola Franke is a PhD candidate in surgical oncology at the Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, in Amsterdam, where she completed her surgical oncology residency. Her research is focused on metastatic melanoma, in particular treatment with T-VEC (oncolytic viral immunotherapy). She is also a resident in dermatology at Erasmus Medical Center (EMC) in Rotterdam.
Dr. Franke received her medical degree from the University of Amsterdam. Her primary interests are in dermatology, oncology, surgery, and research.
Recent Contributions to PracticeUpdate:
- Local or Systemic Treatment of Possible Pulmonary Metastasis?
- Continuation of Dabrafenib + Trametinib Post-Surgery — Yes or No?
- A Different Kind of BRAF Mutation — BRAF/MEKi or Follow-Up?
- Non Responder to Neo-Adjuvant Immunotherapy
- Fit Mid-Fifties Female Patient With Progressive Brain Metastasis, Previous Serious Toxicity on Ipi/Nivo
- Possible Systemic Recurrence and/or Solitary Cutaneous In-Transit Metastasis in 79 Year Old Male Patient
- Wait & See or Switch Immunotherapy With One Single ITM (Removed In Toto With Biopsy) in 72 Years Old Stage III Melanoma Patient
- Recurrent Metastatic Melanoma in Mentally Impaired Patient
- Newly Diagnosed Metastatic Melanoma in a Fit 46-Year-Old Patient
- 43 Year Old Male With Progressive Stage IV Melanoma, Previously Treated With Multiple Adjuvant Systemic Therapies Including 2 Trials